PharMEDium Services LLC has recalled 55 lots of compounded drug products due to a lack of sterility assurance, the Food and Drug Administration announced last week. The products were distributed to U.S. hospitals and clinics. Customers with recalled products should immediately quarantine and destroy them, and may report associated adverse reactions or quality problems to the FDA's MedWatch program.
Hospitals and clinicians are seeing fewer flu patients this season than in other recent years, the Centers for Disease Control and Prevention reports.
Insights and Analysis
Share how your organization is working to improve health equity – apply for the AHA Equity of Care Award Applications for the 2019 AHA Equity of Care Award are due by Feb. 19
Please consider applying for the award and sharing how your organization is improving health equity and value.
Members of the pharmaceutical distribution supply chain, including dispensers such as hospitals and pharmacies, can apply through March 11 to participate in a…
The U.S. District Court for the Western District of Pennsylvania has entered a consent decree prohibiting Ranier’s Rx Laboratory Inc. from manufacturing or…
The Food and Drug Administration Friday warned physicians and patients who use medical devices to monitor levels of the blood thinner warfarin that certain…
The National Highway Traffic Safety Administration’s Office of Emergency Medical Services today released an updated agenda for the nation’s EMS sys